IFNG and primary progressive multiple sclerosis: Cytokines such as interleukin-1 (IL-1) and interferon-gamma (IFN-γ) have been implicated in increasing CA-125 expression in human peritoneal mesothelial cells, leading to the clinical manifestations observed in PPMS [6,7].